Provectus Biopharmaceuticals, Inc. (PVCT)

0.07
OTC Markets
Prev Close 0.06
Day Low/High 0.06 / 0.07
52 Wk Low/High 0.01 / 0.08
Exchange OTC Markets
Shares Outstanding 387.59B
Market Cap 23.18M
Div & Yield N.A. (N.A)

Latest News

Provectus Biopharmaceuticals Will Hold A Business Update Conference Call Thursday - January 5, 2017 At 9 A.m. (EST)

Provectus Biopharmaceuticals Will Hold A Business Update Conference Call Thursday - January 5, 2017 At 9 A.m. (EST)

Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT, www.

Provectus Biopharmaceuticals Terminates Peter Culpepper As Interim CEO And COO

Provectus Biopharmaceuticals Terminates Peter Culpepper As Interim CEO And COO

Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT, www.

CORRECTING and REPLACING Provectus Biopharmaceuticals Announces Two Poster Presentations on PV-10 for Liver Tumors

CORRECTING and REPLACING Provectus Biopharmaceuticals Announces Two Poster Presentations on PV-10 for Liver Tumors

In the subhead and third paragraph of the release, the dates for the Asian Pacific Association for the Study of the Liver (APASL) Conference should read February 15-19, 2017.

(Graphic: Business Wire)

(Graphic: Business Wire)

Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, www.

Provectus Biopharmaceuticals, Inc. Announces Notification Of NYSE MKT Listing Deficiency

Provectus Biopharmaceuticals, Inc. Announces Notification Of NYSE MKT Listing Deficiency

Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT) ( www.

Provectus Biopharmaceuticals Reports Third Quarter 2016 Financial Results

Provectus Biopharmaceuticals Reports Third Quarter 2016 Financial Results

Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT, www.

Provectus Biopharmaceuticals To Present At Sidoti's Fall 2016 Emerging Growth Conference, November 1, 2016

Provectus Biopharmaceuticals To Present At Sidoti's Fall 2016 Emerging Growth Conference, November 1, 2016

Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT, www.

Trading In Provectus Biopharmaceuticals Common Stock And Warrants Suspended By NYSE MKT

Trading In Provectus Biopharmaceuticals Common Stock And Warrants Suspended By NYSE MKT

Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, www.

Provectus Biopharmaceuticals Files Registration Statement For Rights Offering To Existing Stockholders

Provectus Biopharmaceuticals Files Registration Statement For Rights Offering To Existing Stockholders

Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, www.

Provectus Biopharmaceuticals Announces Acceptance Of Abstract For Poster Presentation At 31st SITC Annual Meeting

Provectus Biopharmaceuticals Announces Acceptance Of Abstract For Poster Presentation At 31st SITC Annual Meeting

Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, www.

Provectus Biopharmaceuticals To Present At Rodman & Renshaw's 18th Annual Global Investment Conference

Provectus Biopharmaceuticals To Present At Rodman & Renshaw's 18th Annual Global Investment Conference

Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, www.

Provectus Biopharmaceuticals, Inc. Announces Closing Of Public Offering

Provectus Biopharmaceuticals, Inc. Announces Closing Of Public Offering

Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT) ("Provectus" or the "Company"), a clinical-stage oncology and dermatology biopharmaceutical company, today announced that it has completed its public offering of 240,000...

Provectus Biopharmaceuticals, Inc. Announces Pricing Of Public Offering To Raise $6 Million

Provectus Biopharmaceuticals, Inc. Announces Pricing Of Public Offering To Raise $6 Million

Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, www.

Provectus Biopharmaceuticals, Inc. Announces Proposed Public Offering Of Preferred Stock And Warrants

Provectus Biopharmaceuticals, Inc. Announces Proposed Public Offering Of Preferred Stock And Warrants

Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, www.

Provectus Biopharmaceuticals, Inc. Receives Patent From USPTO Related To Rose Bengal Analogs

Provectus Biopharmaceuticals, Inc. Receives Patent From USPTO Related To Rose Bengal Analogs

Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, www.

Provectus Biopharmaceuticals, Inc. Reports Second Quarter 2016 Financial Results

Provectus Biopharmaceuticals, Inc. Reports Second Quarter 2016 Financial Results

Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT, www.